Oncologists: More Advanced Cancers, Current Tests Not Catching Cancer Recurrence Early Enough
Oncologists are seeing more advanced cancer cases due to screening barriers and are concerned current tests aren’t effective enough.
Read MorePosted by Chris Wolski | May 13, 2025 | Cancer |
Oncologists are seeing more advanced cancer cases due to screening barriers and are concerned current tests aren’t effective enough.
Read MorePosted by Chris Wolski | Apr 30, 2025 | Prostate |
Fellow Health showcased innovative research, emphasizing mail-in semen testing to enhance prostate cancer diagnostics and PVSA care.
Read MorePosted by Chris Wolski | Apr 25, 2025 | Prostate |
Veracyte has launched Decipher Prostate test, a Medicare-covered test for guiding treatment in metastatic prostate cancer.
Read MorePosted by Chris Wolski | Apr 23, 2025 | Prostate |
A new study confirms Cleveland Diagnostics’ IsoPSA test effectively differentiates between low- and high-risk prostate cancer patients.
Read MorePosted by Chris Wolski | Apr 22, 2025 | Cancer |
Liquid biopsy is a groundbreaking, non-invasive method for early cancer detection and monitoring, offering significant clinical potential.
Read More